Amphastar [AMPH] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Amphastar Pharmaceuticals Inc.

NASDAQ
Loading...

Haleon Plc - ADR

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Amphastar Pharmaceuticals Inc. wins in 9 metrics, Haleon Plc - ADR wins in 11 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Amphastar Pharmaceuticals Inc. Haleon Plc - ADR Better
P/E Ratio (TTM) 10.34 18.72 Amphastar Pharmaceuticals Inc.
Price-to-Book Ratio 1.24 1.88 Amphastar Pharmaceuticals Inc.
Debt-to-Equity Ratio 83.16 52.37 Haleon Plc - ADR
PEG Ratio -0.31 15.42 Haleon Plc - ADR
EV/EBITDA 6.11 33.08 Amphastar Pharmaceuticals Inc.
Profit Margin (TTM) 13.63% 15.11% Haleon Plc - ADR
Operating Margin (TTM) 19.45% 23.17% Haleon Plc - ADR
EBITDA Margin (TTM) 19.45% 23.17% Haleon Plc - ADR
Return on Equity 12.90% 10.27% Amphastar Pharmaceuticals Inc.
Return on Assets (TTM) 6.37% 4.67% Amphastar Pharmaceuticals Inc.
Free Cash Flow (TTM) $118.98M $2.22B Haleon Plc - ADR
Dividend Yield N/A 1.63% N/A
1-Year Return -26.68% -20.18% Haleon Plc - ADR
Price-to-Sales Ratio (TTM) 1.32 3.78 Amphastar Pharmaceuticals Inc.
Enterprise Value $1.34B $122.54B Haleon Plc - ADR
EV/Revenue Ratio 1.87 8.23 Amphastar Pharmaceuticals Inc.
Gross Profit Margin (TTM) 46.79% 55.38% Haleon Plc - ADR
Revenue per Share (TTM) $15 $2 Amphastar Pharmaceuticals Inc.
Earnings per Share (Diluted) $2.07 $0.50 Amphastar Pharmaceuticals Inc.
Beta (Stock Volatility) 0.91 0.33 Haleon Plc - ADR
Short % of Float 16.32% 0.43% Haleon Plc - ADR

Amphastar Pharmaceuticals Inc. vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

AMPH
HLN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Amphastar Pharmaceuticals Inc.-1.79%-5.13%-20.32%-8.62%-34.30%-31.52%
Haleon Plc - ADR0.23%-6.44%-5.63%-17.81%-8.31%-12.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Amphastar Pharmaceuticals Inc.-26.68%-59.64%0.32%19.46%79.52%79.52%
Haleon Plc - ADR-20.18%9.16%22.27%22.27%22.27%22.27%

Performance & Financial Health Analysis: Amphastar Pharmaceuticals Inc. vs Haleon Plc - ADR

MetricAMPHHLN
Market Information
Market Cap i$953.49M$42.40B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i454,6916,594,249
90 Day Avg. Volume i496,5747,985,230
Last Close$18.12$8.72
52 Week Range$16.65 - $31.26$8.65 - $11.30
% from 52W High-42.03%-22.83%
All-Time High$67.66 (Aug 07, 2023)$11.42 (Jun 02, 2025)
% from All-Time High-73.22%-23.64%
Growth Metrics
Quarterly Revenue Growth-0.02%0.01%
Quarterly Earnings Growth-0.36%0.86%
Financial Health
Profit Margin (TTM) i0.14%0.15%
Operating Margin (TTM) i0.19%0.23%
Return on Equity (TTM) i0.13%0.10%
Debt to Equity (MRQ) i83.1652.37
Cash & Liquidity
Book Value per Share (MRQ)$17.28$4.99
Cash per Share (MRQ)$6.23$0.15
Operating Cash Flow (TTM) i$156.12M$3.56B
Levered Free Cash Flow (TTM) i$81.37M$1.89B
Dividends
Last 12-Month Dividend Yield iN/A1.63%
Last 12-Month Dividend iN/A$0.17

Valuation & Enterprise Metrics Analysis: Amphastar Pharmaceuticals Inc. vs Haleon Plc - ADR

MetricAMPH (Apr 26, 2026)HLN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i10.3418.72
Forward P/E i6.1815.42
PEG Ratio i-0.3115.42
Price to Sales (TTM) i1.323.78
Price to Book (MRQ) i1.241.88
Market Capitalization
Market Capitalization i$953.49M$42.40B
Enterprise Value i$1.34B$122.54B
Enterprise Value Metrics
Enterprise to Revenue i1.878.23
Enterprise to EBITDA i6.1133.08
Risk & Other Metrics
Beta i0.910.33
Book Value per Share (MRQ) i$17.28$4.99

Financial Statements Comparison: Amphastar Pharmaceuticals Inc. vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAMPH (2025)HLN (2025)
Revenue/Sales i719.89M11.03B
Cost of Goods Sold i363.83M3.95B
COGS % of Revenue i50.5%35.8%
Gross Profit i356.06M7.08B
Gross Margin i49.5%64.2%
Research & Development i85.84M316.00M
Operating Income (EBIT) i140.40M2.41B
Operating Margin i19.5%21.9%
EBITDA i212.31M2.81B
EBITDA Margin i29.5%25.5%
Pre-Tax Income i123.62M2.15B
Pre-Tax Income % of Revenue i17.2%19.5%
Income Tax i25.53M472.00M
Income Tax % of Revenue i3.5%4.3%
Net Income (Profit) i98.09M1.68B
Profit Margin i13.6%15.2%

Balance Sheet & Liquidity Metrics

MetricAMPH (2025)HLN (2025)
Cash & Equivalents i170.18M1.26B
Total Current Assets i636.02M4.55B
Total Current Assets % of Revenue i88.3%41.3%
Total Current Liabilities i158.16M4.93B
Total Current Liabilities % of Revenue i22.0%44.7%
Long-Term Debt i646.43M7.75B
Long-Term Debt % of Revenue i89.8%70.2%
Total Shareholders Equity i788.81M16.48B
Retained Earnings i666.88M27.85B
Retained Earnings % of Revenue i92.6%252.5%
Property, Plant & Equipment i43.15M1.00M

Cash Flow Statement Comparison

MetricAMPH (2025)HLN (2025)
Operating Cash Flow i157.11M2.19B
Operating Cash Flow % of Revenue i21.8%19.8%
Capital Expenditures i-34.88M-322.00M
Free Cash Flow i118.98M2.22B
FCF Margin i16.5%20.1%
Debt Repayment i-223,000-1.35B
Common Stock Repurchase i-75.59M-654.00M

Short Interest & Institutional Ownership Analysis

MetricAMPHHLN
Shares Short i3.53M19.28M
Short Ratio i5.632.14
Short % of Float i16.32%0.43%
Shares Outstanding i45.65M8.91B
Float Shares i33.90M8.86B
% Held by Insiders i29.34%0.01%
% Held by Institutions i78.52%12.74%
% Held by Public i-7.86%87.25%

Dividend Analysis & Yield Comparison: Amphastar Pharmaceuticals Inc. vs Haleon Plc - ADR

MetricAMPHHLN
Last 12-Month Dividend iN/A$0.17
Last 12-Month Dividend Yield iN/A1.63%
3-Year Avg Annual Dividend iN/A$0.11
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$0.34
Ex-Dividend DateN/AApr 25, 2025